Introduction
pattern of oxidation of PG in a Turkish population and to ascertain whether PG metabolism co-segregates with the genetically determined metabolism of mephenytoin Proguanil (PG) is an antimalarial drug used for prophylactic treatment of the infection caused by in Turkish subjects. Plasmodium falciparum. As a prodrug [1 ] it requires cytochrome P450-mediated bioactivation to cycloguanil [ 2] . The parent compound is also excreted unchanged and converted to a minor inactive metabolite, Methods 4-chlorophenylbiguanide (4-Ch). Studies have indicated large inter-subject variability in the plasma concenEighty-nine unrelated healthy subjects, 88 men and 1 woman, with a median age of 20 years (range: 19-21 trations of cycloguanil (CG) in man [3, 4 ] . Based on the population studies using the urinary PG to cycloguyears) were studied. All were students or staff members of Hacettepe University and Gü lhane Military Medical anil (PG/CG) ratio, it was suggested that the oxidative activation of PG shows a polymorphic distibution and Academy, who were born in Turkey with Turkish parents. None of the subjects were regular alcohol users individuals were classified as extensive (PG/CG<10) (EM pro ) or poor (PG/CG >10 ) (PM pro ) metabolizers and had no history of liver or kidney disease. The study was approved by the Ethics Committees of Hacettepe of PG [ 5, 6] . In a subsequent study the oxidative activation of PG was shown to co-segregate with the University Medical Center and the Ministry of Health of Turkey. mephenytoin oxidation polymorphism [ 7] mediated by CYP2C19 [8 ] . Although, there is direct evidence that Each subject took 200 mg proguanil orally. At least 2 weeks later, 39 subjects from this group (37 EM pro and CYP2C19 catalyses the bioactivation of PG, CYP3A also contributes to the reaction [9 ].
2 PM pro ) were given orally 100 mg mephenytoin. No other drug was taken for at least 1 week before and The prevalence of poor metabolizers of PG ranges from 2.2 to 10% in Caucasians [5, 6 ] and from 18 to during the study. Drugs were given immediately after emptying the bladder and a 0-8 h urine sample was 35% in Far-Eastern and other ethnic groups [10] [11] [12] [13] . The present study was undertaken to investigate the collected. A 10 ml aliquot was kept frozen at −20°C for up to 1 month and 3 months before mephenytoin and PG analysis, respectively. PG and CG were determined by h.p.l.c. with u.v. detection [ 14] . The limits of determination for CG and PG were 20 and 100 ng ml−1, respectively. Coefficients of variation for within-day and day-to-day precision were less than 10%. S-and R-mephenytoin were measured by gas chromatography [15] . In the urine samples in which R-mephenytoin but not S-mephenytoin was detected, the S/R-mephenytoin ratio was given a value (0.1) based on the lower level of detection of the S-enantiomer. Subjects with an S/R-mephenytoin ratio above 0.8 were phenotyped as poor metabolizers of mephenytoin (PM meph ) [15] . Correlations were examined using the Spearman's rank test. The frequency distribution profiles and probit plots for urinary PG/CG ratios obtained from 89 healthy volunteers are shown in Figure 1 . The PG/CG ratios ranged Discussion from 1.49 to 50.80. In previous studies in Caucasian populations, subjects with PG/CG ratios greater than
We found a bimodal distribution of the PG/CG ratio in this Turkish population (Figure 1 ). The prevalence of 10 were classified as PM pro [5, 6 ] . However, in the present study, the antimode value for PG/CG ratio in putative PM pro (5.4%; 95% confidence interval from 2.0% to 17.3%) is in the same range as that reported in this Turkish population is 15 by visual inspection (Figure 1 ) . Thus, five subjects with PG/CG ratios >20. 8 Caucasian populations, 2.2-10.0% [5, 6 ] , but lower than in Vietnamese (22%) [ 10] , Thai (18%) [ 11] , were classified as PM pro (5.6%; 95% confidence interval 2% to 17.3%) and the remaining 84 subjects with Khmer (19%) [12 ] and Kenyan (35%) [13] populations. PG/CG ratios <12.6 were classified as EM pro . The S/R-mephenytoin ratios obtained from 39 volun-
The results of this study showed that an antimode ratio of PG/CG of 10 [ 5, 6 ] is not applicable to the teers previously phenotyped with PG (2 PM pro and 37 EM pro ) showed a statistically significant correlation with Turkish population. This conclusion is based on visual inspection of the PG/CG distribution ( Figure 1 ) and the PG/CG ratio (Figure 2 , r s =0.50, P<0.001). Both PM pro were poor metabolizers of mephenytoin. Within supported by the observation that three of the five subjects with PG/CG ratios between 10 to 15 were the subgroup of 37 EM pro subjects, there was also statistically significant correlation between the S/R-EM meph according to their S/R-mephenytoin ratios. Helsby et al. [6] used a PG/CG ratio of 10 to separate mephenytoin and PG/CG ratios (r s =0.41, P<0.01). No subjects participating in the study experienced poor and extensive metabolizers of PG, but in two recent studies [10, 12] in which this antimode value any reported side effect from PG or mephenytoin.
was used, it could not clearly separate two phenotypes of PG on reanalysis of the data. Further evidence that the most appropriate antimode is a PG/CG ratio of 15 is the finding that the five subjects with values between 10 and 15 were genotyped as EM with respect to CYP2C19 (unpublished data).
In agreement with the results of previous studies in Caucasian [7, 16 ] and other populations [10, 14] , our data show that the oxidative activation of PG co-segregates with the 4-hydroxylation of S-mephenytoin in Turkish subjects. This is based on a significant but modest correlation between the S/R-mephenytoin ratio and the PG/CG ratio in 39 Turkish subjects and in the subgroup of 37 EM pro subjects when the 2 PM pro were excluded. Phenotyping the whole population with 
